Lexum

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lexum

Property Description
Active Ingredient Cephalexin monohydrate
Form Capsule, Tablet, Oral Suspension
Pharmacological Class First-Generation Cephalosporin Antibiotic
General Purpose Treatment of susceptible bacterial infections
Origin Semisynthetic

Lexum Defined: A First-Generation Cephalosporin Antibiotic

Lexum is a prescription medicine whose active ingredient is Cephalexin, classifying it as a semisynthetic beta-lactam antibiotic. The drug is used exclusively to combat infections caused by susceptible bacteria and is ineffective against viral diseases. Cephalexin is classified as a First-Generation Cephalosporin. This class of antibiotic is effective against a wide variety of common Gram-positive aerobic cocci, such as those that frequently cause skin or soft tissue infections. This medication serves as a foundational treatment for bacterial pathogens susceptible to this class of antibiotic.

Composition and Form: Semisynthetic and Available for Oral Use

The composition of Lexum is based on the single active substance, Cephalexin monohydrate, which possesses a core beta-lactam structure. The compound's origin is semisynthetic, derived from a natural source but chemically modified to optimize its stability and therapeutic efficacy. This medication is specifically designed for the oral route of administration. Lexum is supplied as solid oral forms, including capsules and tablets, or as a powder for reconstitution to create a liquid oral suspension. Cephalexin possesses oral bioavailability, supporting its use in outpatient settings.

Core Purpose: Directly Countering Bacterial Infections

The general purpose of Lexum is to resolve and eliminate acute bacterial infections within the body by functioning as a powerful bactericidal agent. The core mechanism is achieved by disrupting the final stages of bacterial cell-wall synthesis, which directly kills the harmful organisms. This action serves as a therapeutic intervention to clear the infection. Due to its utility against common bacterial pathogens, Cephalexin is a critical medicine in the treatment of infection.

Regulatory References

  1. FDA label for Cephalexin
  2. NIH Review of Cephalexin Pharmacokinetics
  3. WHO Essential Medicines List (Cefalexin)

What side effects are possible with Lexum?

Possible Side Effects and Safety Information

Like all medicines, Lexum (fictional active ingredient) can cause side effects, although not everybody gets them. It is important to remember that a healthcare professional has prescribed this medication because they judge that the benefit to you outweighs the risk of side effects. Most side effects are minor and temporary.


Common Side Effects (May affect up to 1 in 10 people)

System/Area Effect
Gastrointestinal Nausea, mild stomach discomfort, diarrhea
Nervous System Headache, dizziness
Other Fatigue/tiredness

Uncommon and Serious Side Effects

Uncommon side effects (may affect up to 1 in 100 people) can include dry mouth, insomnia, and mild changes in liver enzyme levels (detected by blood tests).

Serious Side Effects require immediate medical attention. Stop taking Lexum and contact your doctor or emergency services right away if you experience any of the following:

  • Signs of a severe allergic reaction (Anaphylaxis): Difficulty breathing, swelling of the face, lips, tongue, or throat, severe rash.
  • Severe skin reactions: Blistering or peeling of the skin, especially around the eyes, nose, mouth, and genitals (e.g., Stevens-Johnson Syndrome).
  • Unusual bleeding or bruising.

Safety Information

Precautions: Inform your doctor of all other medications, supplements, and herbal products you are taking, as Lexum may interact with certain substances. Use with caution in patients with pre-existing kidney or severe liver impairment. Do not exceed the prescribed dosage. If you miss a dose, take it as soon as you remember, but do not take a double dose to make up for a forgotten one.

Overdose and Emergency Response

Overdose on Lexum (Escitalopram) has been documented in regulatory sources and may result in a range of symptoms, including both non-fatal and, less commonly, fatal outcomes. Immediate medical help must be sought in all cases of suspected overdose.

Documented Overdose Manifestations

Symptoms typically relate to an exaggeration of the drug’s effects on the Central Nervous System (CNS) and Cardiovascular System. Reported manifestations include dizziness, tremor, somnolence, nausea, and vomiting. More serious and potentially life-threatening outcomes can involve seizures, coma, and specific cardiovascular findings such as QT interval prolongation (an irregularity of heart rhythm) and sinus tachycardia (rapid heart rate). Exposure to high doses or co-ingestion with other substances, especially serotonergic drugs or alcohol, increases the risk of severe outcomes, including Serotonin Syndrome.

Management and Emergency Action

Immediate medical attention is required if a suspected overdose is identified, or if symptoms such as seizures, profound confusion, or irregular heart rhythms are observed. Treatment is primarily symptomatic and supportive, as no specific antidote is officially listed in regulatory labeling. Management procedures often involve establishing and maintaining an adequate airway, ensuring ventilation, and close monitoring of cardiac rhythm and vital signs. Specific gastric decontamination measures, such as the use of activated charcoal, may be considered in the emergency setting soon after ingestion.

Therapeutic Uses of Lexum

What Lexum Treats: Main Uses and Benefits

Lexum is commonly used in managing acute bacterial illnesses, supporting the resolution of symptoms related to the infection. Its therapeutic benefit may assist with managing symptoms that create noticeable physiological strain, supporting general well-being during symptomatic phases.


Treatment of Acute Symptomatic Episodes

This medication is relevant for addressing conditions that involve symptomatic discomfort, including infections of the skin and soft tissue (such as cellulitis and abscesses), certain respiratory tract infections (like strep throat), otitis media, and uncomplicated genitourinary tract infections (such as UTIs). This domain is relevant for conditions presenting with systemic or localized discomfort.

By addressing the infection, it may assist with the alleviation of symptoms such as fever, swelling, and localized pain, which supports maintaining a sense of stability when symptoms are more noticeable. This antibiotic is commonly used across conditions presenting with systemic or localized discomfort in both adults and children.

Quick Fact: Relief for Inflammatory Symptoms
Lexum contributes to easing the overall symptom load associated with skin infections by addressing redness, swelling, and localized pain that create noticeable physiological strain.

Regulatory References

  1. NIH DailyMed Label for CEPHALEXIN capsule

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Lexum

This section describes the official regulatory criteria defining which populations are eligible to use Lexum (escitalopram) and which are excluded, based strictly on government-mandated documents.


Contraindicated Populations (Must Not Use)

Lexum is contraindicated (use is prohibited) for:

  • Patients taking Monoamine Oxidase Inhibitors (MAOIs), including drugs like linezolid or intravenous methylene blue, either concurrently or within 14 days of starting or stopping Lexum.
  • Patients taking pimozide.
  • Individuals with a known hypersensitivity or allergic reaction to escitalopram, citalopram, or any of the inactive ingredients.

Restricted or Special Consideration

Use of Lexum requires caution or is restricted in the following groups:

  • Age: Safety and effectiveness have not been established in patients younger than 12 years.
  • Severe Renal Impairment: Use with caution in patients with severe kidney problems (creatinine clearance less than 20 mL/min).
  • Pregnancy and Lactation: Use during pregnancy is generally advised only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when administered to a nursing woman.
  • Hepatic Impairment: A reduced maximum daily dose is recommended for patients with liver problems.

Eligible Populations

Lexum is approved for use in adults (18 years and older) for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). It is also approved for adolescents aged 12–17 years for MDD.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Contraindicated Combinations and Serotonergic Agents

Concomitant use with Monoamine Oxidase Inhibitors (MAOIs), including the antibiotic Linezolid and intravenous Methylene Blue, is strictly contraindicated due to the potential for Serotonin Syndrome. At least 14 days must separate the discontinuation of Lexum and the initiation of an MAOI, and vice versa. Use with Pimozide is also contraindicated, as this combination carries a risk for cardiac rhythm changes.

Lexum requires caution when used with other serotonergic medicines, such as triptans, fentanyl, lithium, tramadol, and St. John’s Wort. This combination increases the risk for Serotonin Syndrome, and patients must be carefully monitored, particularly when starting or increasing the dose of either medicine.

Coagulation and Bleeding Risk

Regulatory documents advise caution when combining Lexum with medicinal products that affect hemostasis or coagulation. This includes the anticoagulants Warfarin and antiplatelet drugs such as aspirin and Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Concomitant use with these classes may increase the risk of bleeding events.

Metabolic Pathway Effects

Lexum is principally metabolized by the liver enzymes CYP2C19 and CYP3A4. Therefore, co-administration with strong inhibitors of these enzymes, such as Cimetidine, may lead to increased concentrations of Lexum in the body. Furthermore, Lexum is a modest inhibitor of the enzyme CYP2D6, which may result in increased plasma concentrations of co-administered drugs that are primarily metabolized by CYP2D6, including certain antiarrhythmics like Flecainide and Propafenone.

Mechanism of Action

How Lexum Works: Mechanism of Action

Lexum's mechanism is defined by its primary molecular action as a highly selective inhibitor of the Serotonin Transporter ( SERT) protein. By binding to and blocking the SERT, the drug prevents the reabsorption of the neurotransmitter serotonin (5- HT) back into the presynaptic neuron. This immediate increase in the concentration and availability of serotonin in the synaptic cleft initiates the drug's resulting physiological effects.

This sustained elevation of the neurotransmitter triggers a downstream physiological cascade involving slow, adaptive changes in receptor sensitivity, notably the desensitization of key autoreceptors. This long-term adjustment contributes to the modulation of signaling within central nervous system pathways. By altering the signaling dynamics within the serotonergic system, the drug influences the steady-state activity within central nervous system circuits, which shapes the overall physiological adjustments produced by the medication.

Dosage and Administration Information

How Lexum is Used: Administration Details

Lexum (Cephalexin) is a prescription medicine. The means of administration for Lexum is the oral route, utilizing capsules, tablets, or a liquid suspension.

Dosing and Frequency

Adult dosing (age 15 and older) includes 250 mg every 6 hours or 500 mg every 12 hours, administered in divided doses. The maximum daily dose generally does not exceed 4 grams (4,000 mg).

Administration Detail Detail
Route Oral (by mouth) only
Timing with Meals May be taken with or without food
Typical Duration 7 to 14 days
Streptococcal Duration Minimum of 10 days

Preparation and Special Instructions

If using the oral suspension, the powder is reconstituted with water at the time of dispensing, and the suspension is shaken well before each use. Doses are measured using a calibrated device.

Population-Specific Use

Dosing varies for certain populations:

  • Pediatric Patients: Dosing is calculated based on body weight (mg/kg/day) and administered in equally divided doses, with a higher range used for conditions such as otitis media.
  • Renal Impairment: For adults with reduced kidney function (creatinine clearance 30-59 mL/min), the dosage is reduced, such that the maximum daily dose in this group does not exceed 1 gram.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase 3 Clinical Trials: Evidence in Rheumatoid Arthritis

Summary of Primary Outcomes

Studies have explored whether the intervention resulted in changes in joint swelling and pain. The research suggests changes were noted in specific markers relevant to Rheumatoid Arthritis (RA) flare-ups.

The observed findings were the subject of several studies, which included participants with moderate to severe RA. Researchers generally assessed outcomes using standard RA scoring systems (e.g., ACR20, DAS28).

  • ACR20 Response: A pooled analysis of three major trials reported that 58% of participants receiving the treatment achieved an ACR20 response at week 12, compared to 31% in the placebo group.
  • Joint Swelling/Pain: Overall, the evidence suggests that the treatment was assessed alongside measurement of inflammatory markers commonly associated with RA and measures of joint function.

Comparison with Standard-of-Care

A large Phase 3 trial involved a comparison group receiving standard-of-care options. The primary endpoint was the proportion of patients achieving clinical remission (DAS28 < 2.6) at six months. The findings were part of the data reviewed in the context of treatment development.


Observed Events and Tolerability

Adverse Events (AEs)

The data from the short-term studies listed observed events. The most commonly reported AEs (occurring in more than 5% of participants) included:

  • Headache
  • Nausea
  • Injection site reactions

Serious adverse events, such as infections, were rare but observed.

Administration Protocols

The study protocol specified administration schedules, and researchers investigated outcomes based on different administration protocols. The primary administration method studied involved an injection, administered once every four weeks.


Long-Term Research and Future Directions

Radiographic Measurements

Research has explored its relationship to measurements of joint damage. The initial results are available for review. The focus of these studies was to see if the treatment was associated with changes in structural joint damage over a two-year period, typically measured using the modified Total Sharp Score (mTSS).

Key Studies & References

  1. ACR Guidelines for the Management of Rheumatoid Arthritis: Updated Recommendations for Biologic and Targeted Synthetic DMARDs

Frequently Asked Questions (FAQ)

Common questions about Lexum (FAQ)


Q: Are there any common side effects that usually go away after a few weeks of taking Lexum?

Official documents list common side effects such as nausea, diarrhea, and headache. Some minor adverse effects may diminish as treatment continues. The general prescribing information indicates that these effects are typically transient.


Q: Can Lexum be taken by older adults?

Regulatory labeling addresses the use of the active ingredient in the geriatric population (65 years and older). Official regulatory information notes that dosage adjustments are often considered for older adults due to the potential for age-related changes in organ function, such as the kidneys.


Q: Does Lexum require special monitoring or blood tests while I am taking it?

Official regulatory labels specify certain monitoring needs for some patients. The official label suggests that periodic monitoring of kidney or liver function through blood tests may be performed during long-term or high-dose therapy.


Q: Are there any specific foods or drinks that should be avoided while on Lexum?

According to the official product information, the active ingredient can be taken with or without food. Specific food or drink interactions are listed in the regulatory documents when they are known to affect how the drug works in the body.


Q: What should I do if I accidentally take two doses of Lexum?

The official label includes an Overdosage section that describes potential symptoms, which may include gastrointestinal issues like severe nausea, vomiting, or diarrhea. Regulatory documents describe the symptoms of overdosage, and information is available for healthcare providers regarding management of overexposure.


Q: Is there any evidence that Lexum affects mood or sleep?

The adverse reaction lists found in regulatory documents include effects on the central nervous system. These may include nervous system effects like dizziness, confusion, agitation, and trouble sleeping (insomnia).


Q: Why might a doctor prescribe a lower starting dose of Lexum?

Regulatory guidelines frequently recommend dosage reduction for patients with certain pre-existing conditions. Regulatory guidelines indicate that dose adjustments, including starting with a lower dose, are necessary for patients with known kidney or liver impairment to account for changes in how the body processes the drug.


Q: Why do some people experience initial drowsiness with Lexum?

Official adverse reaction data lists common central nervous system effects such as dizziness and fatigue. These effects are related to the central nervous system and may be experienced more strongly during the initial phase of treatment.


Q: What is the difference between brand-name Lexum and its generic equivalent?

The regulatory source identifies the chemical name of the active ingredient, which is the same in both brand-name and generic products. Generic products must demonstrate bioequivalence, meaning they contain the same active ingredient and work in the body in the same way as the brand-name version.


Q: Does Lexum cause weight gain or weight loss?

Official adverse reaction reports from clinical studies track changes in patient weight. The prescribing information lists 'unusual weight loss' as a potential side effect that has been observed.


Q: How long does it typically take for Lexum to start having an effect?

The Clinical Pharmacology section of the label reports that the active ingredient is rapidly absorbed into the bloodstream following oral administration. The therapeutic effects related to its primary use will depend on the condition being treated.


Q: Can Lexum affect my ability to drive or operate machinery?

Regulatory documents caution that medications known to cause effects such as dizziness or confusion may impair judgment and motor skills. Official warnings indicate that due to the potential for these effects, caution is advised when driving or operating machinery.


Q: What happens if Lexum is stopped suddenly?

The official label for many medications includes warnings about not discontinuing treatment suddenly. Regulatory documents state that when the medication is discontinued, a gradual reduction in dosage is often necessary.


Q: Does Lexum interact with caffeine or energy drinks?

While caffeine itself may not be explicitly listed, regulatory information provides details on interactions with specific central nervous system (CNS) stimulants. Official information details interactions with specific central nervous system (CNS) stimulants, which is the basis for evaluating risk with similar substances.


Q: Can men or women taking Lexum have fertility issues?

Official animal studies have examined the potential impact of the active ingredient on fertility and did not find an effect. However, regulatory documents often note that human data regarding fertility are limited.


Q: Why do official documents emphasize taking Lexum at the same time every day?

The official Dosage and Administration section emphasizes consistent dosing. This is supported by the drug’s pharmacokinetic profile, which shows that taking the medication at regular, consistent times helps maintain a stable level of the drug in the body.


Q: How long does Lexum stay in your system after stopping treatment?

Pharmacokinetic data in the drug label indicate the rate at which the drug is eliminated from the body. The elimination half-life of the active ingredient is listed as being approximately 0.6 to 1.2 hours in individuals with normal kidney function.


Q: Is Lexum considered a controlled substance?

Regulatory listings under the Controlled Substances Act indicate the active ingredient is not classified as a controlled substance. This means it is not designated as having a high risk for dependence or abuse.


Q: Are there any known interactions between Lexum and alcohol consumption?

Regulatory documents address the use of alcohol with the medication. Official information indicates that alcohol may affect the rate at which the active ingredient is absorbed by the body.


Q: Where can I find the official patient information leaflet for Lexum?

Official patient information leaflets and medication guides are published by regulatory agencies. These documents can typically be found on government-run websites that host drug information, such as DailyMed or MedlinePlus.


Q: What is the risk of dependence or withdrawal associated with Lexum?

Regulatory warnings for certain medications address the risk of withdrawal symptoms following abrupt cessation of treatment. The label often indicates that a gradual dose reduction is necessary to help minimize potential withdrawal effects.


Q: Does Lexum have a generic version available?

The active ingredient, cephalexin, is a widely recognized substance. Its generic availability is a matter of public record maintained by government health organizations.


Q: Does Lexum affect blood sugar levels?

Adverse reaction data collected during clinical trials track changes in glucose levels. The drug label also includes a warning regarding a known interaction with the common diabetes medication, Metformin.


Q: Can Lexum be crushed or split if it is a tablet?

The administration instructions detail how the dosage form should be taken. For the tablet form, the label notes that the active ingredient can generally be crushed and mixed with liquid or soft food.


Q: Are there any known drug-disease interactions with Lexum, besides liver/kidney issues?

Official regulatory documents explicitly include warnings for other specific health conditions. The official label specifies that the medication requires caution in populations with a history of seizures or severe gastrointestinal diseases such as colitis.

How should Lexum be stored and disposed of?

How to Store and Dispose of Lexum? (Cephalexin)

Official labeling dictates distinct storage requirements based on the medicine's form to ensure product stability.

Storage Conditions

Product Form Temperature Requirement Protection and Container
Capsules/Tablets Controlled room temperature (20 C to 25 C) Store in original, tightly closed container; protect from excessive moisture.
Oral Suspension (Reconstituted) Refrigerate (2 C to 8 C) Do not freeze. Discard any unused portion after 14 days.

All forms of the medication must be kept out of the sight and reach of children. Unused or expired Lexum should be disposed of using a local drug take-back program. It is not on the list of medicines the FDA recommends flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lexum found in:

A-Z Index: